Home
About Us
About Us
Board of Directors
Scientific Advisory Board
Management Team
Careers
For Researchers
Paxalisib
EVT801
Collaborating with Kazia
Publications and Presentations
For Partners
Our Current Partners
What We Are Looking For
For Patients
Accessing Kazia Drug Candidates in Clinical Trials
Accessing Kazia Drug Candidates for Compassionate Use
Resources for Patients
For Investors
Press Releases
ASX Announcements
Delisting from ASX
How to convert unlisted shares to ADSs
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
AGM
Corporate Governance
Shareholder Services
Media Centre
Overview
Video
Coverage
Contact
Contact Us
Subscribe to email alerts
Heading &
Sub-heading can be edited through HQI
Home
>
For Investors
>
Annual Reports
Press Releases
ASX Announcements
Delisting from ASX
How to convert unlisted shares to ADSs
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
AGM
Corporate Governance
Shareholder Services
Annual Reports
11-Mar-2025
2024 Annual Report
31-Aug-2023
Appendix 4E and 2023 Annual Report
29-Aug-2022
Kazia Annual Report to shareholders
26-Aug-2021
Kazia Annual Report to shareholders
27-Aug-2020
Kazia Annual Report to shareholders
29-Aug-2019
Kazia Annual Report to shareholders
8-Oct-2018
Kazia Annual Report to shareholders
16-Oct-2017
Novogen Annual Report to shareholders
30-Aug-2017
Novogen financial report and Appendix 4E
30-Aug-2017
Novogen annual report and full year financial results
